Dialight594-2401-013F | 594 Series Prism® Circuit Board IndicatorsLEDs

594 Series Prism® Surface Mount LED, 1.6mm Round Lens, 20mA and 2mA

Dialight 594 Prism® LED Circuit Board Indicators are single-level, right-angle indicators with a small board footprint. These LED indicators feature a diffused, 1.6mm lens for better visibility and are designed to withstand 260°C peak reflow temperature. The dominant wavelength of these Prism® LED indicators ranges from 525nm to 630nm with a luminous intensity range from 2mcd to 312mcd. Their proprietary single-level design are ideal for applications such as board-edge mounting in network interface cards, networking hardware, wireless components, testing- and measuring equipment.

The 594 Prism LED indicators are compatible with automatic placement equipment. Available in standard 20mA forward current (IF) version in red, orange, yellow, yellow-green, and green colors. These LEDs also offer a low-power 2mA forward current (IF) version in white, red, yellow, orange, and ice blue colors. The 594 Prism LED indicators come in 4.5mm x 3.3mm x 4.2mm dimensions. Great Things Come in Small Packages.

Download Customer Drawing




Import TariffMay apply to this part

13 parts: Ships tomorrow

    Total$0.07Price for 1

    • Service Fee  $7.00

      Ships tomorrow

      Ships from:
      United States of America
      Date Code:
      2101+
      Manufacturer Lead Time:
      10 weeks
      Minimum Of :
      1
      Maximum Of:
      13
      Country Of origin:
      Malaysia
         
      • Price: $0.0658
      Spliced leader/trailer tape per EIA standards Leader tape:400mm=15.75'; Trail tape:160mm=6.3' more information
    • Ships tomorrow

      Ships from:
      United States of America
      Date Code:
      2101+
      Manufacturer Lead Time:
      10 weeks
      Country Of origin:
      Malaysia
      • In Stock: 13 parts
      • Price: $0.0658

    Design AI-powered medical devices

    Explore system design tips, part recs and AI insights to help you build faster, safer diagnostic and therapy solutions—all in Arrow’s latest white paper.